Regeneron Pharmaceuticals, Inc.
ANTI- PDGF-B ANTIBODIES AND METHODS OF USE FOR TREATING PULMONARY ARTERIAL HYPERTENSION (PAH)

Last updated:

Abstract:

The present disclosure provides anti-Platelet-Derived Growth Factor Subunit B (PDGF-B) antibodies, and antigen-binding fragments thereof, as well as methods of use of such antibodies, or antigen-binding fragments thereof, for treating a subject having pulmonary arterial hypertension (PAH).

Status:
Application
Type:

Utility

Filling date:

25 Jan 2022

Issue date:

4 Aug 2022